These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct-to-consumer prescription drug advertising: history, regulation, and issues. Huh J, DeLorme DE, Reid LN, An S. Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178 [Abstract] [Full Text] [Related]
10. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Morgan S, Mintzes B, Barer M. J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759 [Abstract] [Full Text] [Related]
11. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC. Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
12. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications. Kopp SW, Bang HK. Health Mark Q; 2000 Dec; 17(3):39-56. PubMed ID: 11010219 [Abstract] [Full Text] [Related]
13. Direct-to-consumer drug marketing: public service or disservice? Berger JT, Kark P, Rosner F, Packer S, Bennett AJ. Mt Sinai J Med; 2001 May; 68(3):197-202. PubMed ID: 11373692 [Abstract] [Full Text] [Related]
15. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Rosenthal M. J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239 [No Abstract] [Full Text] [Related]